Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Arvinas Inc (NASDAQ: ARVN) closed at $26.52 down -0.19% from its previous closing price of $26.57. In other words, the price has decreased by -$0.19 from its previous closing price. On the day, 0.69 million shares were traded. ARVN stock price reached its highest trading level at $26.72 during the session, while it also had its lowest trading level at $25.71.
Ratios:
For a deeper understanding of Arvinas Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.62 and its Current Ratio is at 3.62. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on February 28, 2024, Reiterated its Outperform rating but revised its target price to $80 from $95 previously.
On February 14, 2024, Citigroup Downgraded its rating to Neutral which previously was Buy and also upped its target price recommendation from $36 to $55.
On February 01, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $70.Goldman initiated its Buy rating on February 01, 2024, with a $70 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 23 ’24 when Houston John G sold 5,196 shares for $47.05 per share. The transaction valued at 244,472 led to the insider holds 1,036,681 shares of the business.
Cassidy Sean A sold 1,702 shares of ARVN for $80,079 on Feb 23 ’24. The Chief Financial Officer now owns 181,916 shares after completing the transaction at $47.05 per share. On Feb 23 ’24, another insider, Peck Ronald, who serves as the Chief Medical Officer of the company, sold 1,699 shares for $47.05 each. As a result, the insider received 79,938 and left with 67,516 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ARVN now has a Market Capitalization of 1823979392 and an Enterprise Value of 593946560. For the stock, the TTM Price-to-Sale (P/S) ratio is 19.51 while its Price-to-Book (P/B) ratio in mrq is 3.03. Its current Enterprise Value per Revenue stands at 6.366 whereas that against EBITDA is -1.622.
Stock Price History:
Over the past 52 weeks, ARVN has reached a high of $53.08, while it has fallen to a 52-week low of $13.57. The 50-Day Moving Average of the stock is 4.60%, while the 200-Day Moving Average is calculated to be -19.35%.
Shares Statistics:
For the past three months, ARVN has traded an average of 580.62K shares per day and 493690 over the past ten days. A total of 68.00M shares are outstanding, with a floating share count of 59.43M. Insiders hold about 13.42% of the company’s shares, while institutions hold 98.90% stake in the company. Shares short for ARVN as of 1727654400 were 10672118 with a Short Ratio of 18.38, compared to 1724976000 on 13182747. Therefore, it implies a Short% of Shares Outstanding of 10672118 and a Short% of Float of 15.83.
